Home Molecular Diagnostics/In vitro Diagnostics Companion Diagnostics

Companion Diagnostics

    Latest
    Companion Diagnostics

    FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer

    Source: Thermo Fisher Scientific
    Companion Diagnostics

    New Thermo Fisher Center Offers Access to Precision Medicine Technologies, Expertise

    Companion Diagnostics

    FDA Extends Approval for Qiagen NSCLC Test as CDx to Boehringer...

    Foundation Medicine says the companion diagnostics it plans to develop with Pfizer would be launched as updates to the company’s FoundationOne CDx
    Companion Diagnostics

    Pfizer Joins Foundation Medicine to Develop Cancer CDx

    Companion Diagnostics

    FDA, CMS Approve Foundation Medicine’s Solid Tumor Test with Proposed Coverage

    At a personalized medicine meeting in Boston
    Companion Diagnostics

    Illumina’s Jay Flatley: In “Shock and Awe” at State of Personalized...

    Companion Diagnostics

    FDA Clears Thermo Fisher NGS Companion Diagnostic for Three NSCLC Treatments

    Companion Diagnostics

    CDx for Agios Cancer Candidate to Be Developed by Thermo Fisher...

    Companion Diagnostics

    Clovis Partners with Myriad on Diagnostic for Ovarian Cancer Treatment

    Companion Diagnostics

    R-Biopharm, Merck KGaA Launch Companion Diagnostics Collaboration

    123...19Page 1 of 19
    Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.